4737 — Bionime Cashflow Statement
0.000.00%
Last trade - 00:00
- TWD4.20bn
- TWD6.57bn
- TWD1.76bn
- 13
- 24
- 57
- 17
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 135 | 31.1 | 74.6 | 86.5 | -31.9 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 57.3 | 58.9 | 10.6 | 71.3 | 12.2 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 49.2 | -35.9 | 29.9 | -169 | 59.7 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 406 | 218 | 270 | 142 | 203 |
Capital Expenditures | -138 | -296 | -285 | -313 | -441 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 8.98 | -34.4 | -3.5 | 0.665 | 6.14 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -129 | -331 | -288 | -312 | -435 |
Financing Cash Flow Items | 2 | 0.393 | 0.557 | -0.071 | -1.08 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -338 | 96.3 | -69.3 | 114 | 420 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -74.1 | -16.3 | -90.2 | -38.6 | 177 |